Abstract
Background: Experimental studies have demonstrated that bone marrow stem cells can migrate into peripheral blood and regenerate damaged myocardium.
Hypothesis: Bone marrow stimulation might improve myocardial functional recovery after acute myocardial infarction (AMI).
Methods: In all, 104 consecutive patients with anterior wall AMI treated by primary coronary angioplasty and stenting within 12 h after onset, and who underwent left ventriculography on admission and 6 months after discharge, were studied. Among these, 23 patients (Group 1) demonstrated transient appearance of immature blood cells including myelocytes, promyelocytes, and myeloblasts during hospital stay. Thirty‐eight matched patients in whom no immature blood cells were detected were studied as a control group (Group 2).
Results: There was no significant difference in baseline characteristics between the two groups. There was no significant difference in left ventricular ejection fraction (EF) on admission between Group 1 (33 ± 12%) and Group 2 (34 ± 8%). In contrast, EF was significantly better in Group 1 (47 ± 12%) than in Group 2 (40 ± 10%, p = 0.016) 6 months after discharge.
Conclusion: The study suggests significantly greater improvement in left ventricular function in patients with AMI with sign of bone marrow stimulation than in matched patients with no sign of bone marrow stimulation.
Keywords: myocardial infarction, left ventricular function, bone marrow stem cell
Full Text
The Full Text of this article is available as a PDF (25.8 KB).
References
- 1. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal‐Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P: Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750–1757 [DOI] [PubMed] [Google Scholar]
- 2. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Wang BJ, Homma S, Edwards NM, Itescu S: Neovascularization of ischemic myocardium by human bone‐marrow‐derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Med 2001; 7: 430–436 [DOI] [PubMed] [Google Scholar]
- 3. Tomita S, Li RK, Weisel RD, Mickle DAG, Kim EJ, Sakai T, Jia ZQ: Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999; 100:II‐247–II‐256 [DOI] [PubMed] [Google Scholar]
- 4. Asahara T, Masuda T, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221–228 [DOI] [PubMed] [Google Scholar]
- 5. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal‐Ginard B, Bodine DM, Leri A, Anversa P: Bone marrow cells renegerate infarcted myocardium. Nature 2001; 410: 701–705 [DOI] [PubMed] [Google Scholar]
- 6. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, Sano M, Takahashi T, Hori S, Abe H, Hata J, Umezawa A, Ogawa S: Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 1999; 103: 679–705 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T: Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001; 103: 2776–2779 [DOI] [PubMed] [Google Scholar]
